 | • レポートコード：QFJ1-4936 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、T細胞リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、外科療法、幹細胞移植療法、その他）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・T細胞リンパ腫治療の市場動向 ・企業の競争状況、市場シェア ・T細胞リンパ腫治療の種類別市場規模と予測2016-2027（化学療法、放射線療法、外科療法、幹細胞移植療法、その他） ・T細胞リンパ腫治療の用途別市場規模と予測2016-2027（病院、診療所、外来手術センター、その他） ・T細胞リンパ腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・T細胞リンパ腫治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・T細胞リンパ腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・T細胞リンパ腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・T細胞リンパ腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（BioCryst Pharmaceuticals、Johnson & Johnson、Novartis、Merck、Bristol-Myers Squibb、Genmab AS、Shionogi、Spectrum Pharmaceuticals、Seattle Genetics、Shenzhen ChipScreen Biosciences, Ltd.、Medivir AB、Amgen、Eisai Co., Ltd.、Sorrento Therapeutics） ・結論 |
Market Analysis and Insights: Global T-Cell Lymphoma Treatment Market
The global T-Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global T-Cell Lymphoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global T-Cell Lymphoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global T-Cell Lymphoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global T-Cell Lymphoma Treatment market.
Global T-Cell Lymphoma Treatment Scope and Market Size
T-Cell Lymphoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global T-Cell Lymphoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Radiation Therapy
Surgical Therapy
Stem Cell Transplantation Therapy
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
BioCryst Pharmaceuticals
Johnson & Johnson
Novartis
Merck
Bristol-Myers Squibb
Genmab AS
Shionogi
Spectrum Pharmaceuticals
Seattle Genetics
Shenzhen ChipScreen Biosciences, Ltd.
Medivir AB
Amgen
Eisai Co., Ltd.
Sorrento Therapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T-Cell Lymphoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Surgical Therapy
1.2.5 Stem Cell Transplantation Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global T-Cell Lymphoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global T-Cell Lymphoma Treatment Market Perspective (2016-2027)
2.2 T-Cell Lymphoma Treatment Growth Trends by Regions
2.2.1 T-Cell Lymphoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 T-Cell Lymphoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 T-Cell Lymphoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 T-Cell Lymphoma Treatment Industry Dynamic
2.3.1 T-Cell Lymphoma Treatment Market Trends
2.3.2 T-Cell Lymphoma Treatment Market Drivers
2.3.3 T-Cell Lymphoma Treatment Market Challenges
2.3.4 T-Cell Lymphoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top T-Cell Lymphoma Treatment Players by Revenue
3.1.1 Global Top T-Cell Lymphoma Treatment Players by Revenue (2016-2021)
3.1.2 Global T-Cell Lymphoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global T-Cell Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by T-Cell Lymphoma Treatment Revenue
3.4 Global T-Cell Lymphoma Treatment Market Concentration Ratio
3.4.1 Global T-Cell Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T-Cell Lymphoma Treatment Revenue in 2020
3.5 T-Cell Lymphoma Treatment Key Players Head office and Area Served
3.6 Key Players T-Cell Lymphoma Treatment Product Solution and Service
3.7 Date of Enter into T-Cell Lymphoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 T-Cell Lymphoma Treatment Breakdown Data by Type
4.1 Global T-Cell Lymphoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global T-Cell Lymphoma Treatment Forecasted Market Size by Type (2022-2027)
5 T-Cell Lymphoma Treatment Breakdown Data by Application
5.1 Global T-Cell Lymphoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global T-Cell Lymphoma Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America T-Cell Lymphoma Treatment Market Size (2016-2027)
6.2 North America T-Cell Lymphoma Treatment Market Size by Type
6.2.1 North America T-Cell Lymphoma Treatment Market Size by Type (2016-2021)
6.2.2 North America T-Cell Lymphoma Treatment Market Size by Type (2022-2027)
6.2.3 North America T-Cell Lymphoma Treatment Market Size by Type (2016-2027)
6.3 North America T-Cell Lymphoma Treatment Market Size by Application
6.3.1 North America T-Cell Lymphoma Treatment Market Size by Application (2016-2021)
6.3.2 North America T-Cell Lymphoma Treatment Market Size by Application (2022-2027)
6.3.3 North America T-Cell Lymphoma Treatment Market Size by Application (2016-2027)
6.4 North America T-Cell Lymphoma Treatment Market Size by Country
6.4.1 North America T-Cell Lymphoma Treatment Market Size by Country (2016-2021)
6.4.2 North America T-Cell Lymphoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe T-Cell Lymphoma Treatment Market Size (2016-2027)
7.2 Europe T-Cell Lymphoma Treatment Market Size by Type
7.2.1 Europe T-Cell Lymphoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe T-Cell Lymphoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe T-Cell Lymphoma Treatment Market Size by Type (2016-2027)
7.3 Europe T-Cell Lymphoma Treatment Market Size by Application
7.3.1 Europe T-Cell Lymphoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe T-Cell Lymphoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe T-Cell Lymphoma Treatment Market Size by Application (2016-2027)
7.4 Europe T-Cell Lymphoma Treatment Market Size by Country
7.4.1 Europe T-Cell Lymphoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe T-Cell Lymphoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific T-Cell Lymphoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Type
8.2.1 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Application
8.3.1 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Region
8.4.1 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific T-Cell Lymphoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America T-Cell Lymphoma Treatment Market Size (2016-2027)
9.2 Latin America T-Cell Lymphoma Treatment Market Size by Type
9.2.1 Latin America T-Cell Lymphoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America T-Cell Lymphoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America T-Cell Lymphoma Treatment Market Size by Type (2016-2027)
9.3 Latin America T-Cell Lymphoma Treatment Market Size by Application
9.3.1 Latin America T-Cell Lymphoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America T-Cell Lymphoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America T-Cell Lymphoma Treatment Market Size by Application (2016-2027)
9.4 Latin America T-Cell Lymphoma Treatment Market Size by Country
9.4.1 Latin America T-Cell Lymphoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America T-Cell Lymphoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa T-Cell Lymphoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Type
10.2.1 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Application
10.3.1 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Country
10.4.1 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa T-Cell Lymphoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BioCryst Pharmaceuticals
11.1.1 BioCryst Pharmaceuticals Company Details
11.1.2 BioCryst Pharmaceuticals Business Overview
11.1.3 BioCryst Pharmaceuticals T-Cell Lymphoma Treatment Introduction
11.1.4 BioCryst Pharmaceuticals Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.1.5 BioCryst Pharmaceuticals Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson T-Cell Lymphoma Treatment Introduction
11.2.4 Johnson & Johnson Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis T-Cell Lymphoma Treatment Introduction
11.3.4 Novartis Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck T-Cell Lymphoma Treatment Introduction
11.4.4 Merck Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb T-Cell Lymphoma Treatment Introduction
11.5.4 Bristol-Myers Squibb Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Genmab AS
11.6.1 Genmab AS Company Details
11.6.2 Genmab AS Business Overview
11.6.3 Genmab AS T-Cell Lymphoma Treatment Introduction
11.6.4 Genmab AS Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.6.5 Genmab AS Recent Development
11.7 Shionogi
11.7.1 Shionogi Company Details
11.7.2 Shionogi Business Overview
11.7.3 Shionogi T-Cell Lymphoma Treatment Introduction
11.7.4 Shionogi Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.7.5 Shionogi Recent Development
11.8 Spectrum Pharmaceuticals
11.8.1 Spectrum Pharmaceuticals Company Details
11.8.2 Spectrum Pharmaceuticals Business Overview
11.8.3 Spectrum Pharmaceuticals T-Cell Lymphoma Treatment Introduction
11.8.4 Spectrum Pharmaceuticals Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.8.5 Spectrum Pharmaceuticals Recent Development
11.9 Seattle Genetics
11.9.1 Seattle Genetics Company Details
11.9.2 Seattle Genetics Business Overview
11.9.3 Seattle Genetics T-Cell Lymphoma Treatment Introduction
11.9.4 Seattle Genetics Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.9.5 Seattle Genetics Recent Development
11.10 Shenzhen ChipScreen Biosciences, Ltd.
11.10.1 Shenzhen ChipScreen Biosciences, Ltd. Company Details
11.10.2 Shenzhen ChipScreen Biosciences, Ltd. Business Overview
11.10.3 Shenzhen ChipScreen Biosciences, Ltd. T-Cell Lymphoma Treatment Introduction
11.10.4 Shenzhen ChipScreen Biosciences, Ltd. Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.10.5 Shenzhen ChipScreen Biosciences, Ltd. Recent Development
11.11 Medivir AB
11.11.1 Medivir AB Company Details
11.11.2 Medivir AB Business Overview
11.11.3 Medivir AB T-Cell Lymphoma Treatment Introduction
11.11.4 Medivir AB Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.11.5 Medivir AB Recent Development
11.12 Amgen
11.12.1 Amgen Company Details
11.12.2 Amgen Business Overview
11.12.3 Amgen T-Cell Lymphoma Treatment Introduction
11.12.4 Amgen Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.12.5 Amgen Recent Development
11.13 Eisai Co., Ltd.
11.13.1 Eisai Co., Ltd. Company Details
11.13.2 Eisai Co., Ltd. Business Overview
11.13.3 Eisai Co., Ltd. T-Cell Lymphoma Treatment Introduction
11.13.4 Eisai Co., Ltd. Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.13.5 Eisai Co., Ltd. Recent Development
11.14 Sorrento Therapeutics
11.14.1 Sorrento Therapeutics Company Details
11.14.2 Sorrento Therapeutics Business Overview
11.14.3 Sorrento Therapeutics T-Cell Lymphoma Treatment Introduction
11.14.4 Sorrento Therapeutics Revenue in T-Cell Lymphoma Treatment Business (2016-2021)
11.14.5 Sorrento Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global T-Cell Lymphoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Surgical Therapy
Table 5. Key Players of Stem Cell Transplantation Therapy
Table 6. Key Players of Others
Table 7. Global T-Cell Lymphoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global T-Cell Lymphoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global T-Cell Lymphoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global T-Cell Lymphoma Treatment Market Share by Regions (2016-2021)
Table 11. Global T-Cell Lymphoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global T-Cell Lymphoma Treatment Market Share by Regions (2022-2027)
Table 13. T-Cell Lymphoma Treatment Market Trends
Table 14. T-Cell Lymphoma Treatment Market Drivers
Table 15. T-Cell Lymphoma Treatment Market Challenges
Table 16. T-Cell Lymphoma Treatment Market Restraints
Table 17. Global T-Cell Lymphoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global T-Cell Lymphoma Treatment Market Share by Players (2016-2021)
Table 19. Global Top T-Cell Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-Cell Lymphoma Treatment as of 2020)
Table 20. Ranking of Global Top T-Cell Lymphoma Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by T-Cell Lymphoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players T-Cell Lymphoma Treatment Product Solution and Service
Table 24. Date of Enter into T-Cell Lymphoma Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global T-Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global T-Cell Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global T-Cell Lymphoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global T-Cell Lymphoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global T-Cell Lymphoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global T-Cell Lymphoma Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global T-Cell Lymphoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global T-Cell Lymphoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America T-Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America T-Cell Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America T-Cell Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America T-Cell Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America T-Cell Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America T-Cell Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe T-Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe T-Cell Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe T-Cell Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe T-Cell Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe T-Cell Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe T-Cell Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific T-Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific T-Cell Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific T-Cell Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific T-Cell Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific T-Cell Lymphoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific T-Cell Lymphoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America T-Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America T-Cell Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America T-Cell Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America T-Cell Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America T-Cell Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America T-Cell Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa T-Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa T-Cell Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa T-Cell Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa T-Cell Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa T-Cell Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa T-Cell Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. BioCryst Pharmaceuticals Company Details
Table 65. BioCryst Pharmaceuticals Business Overview
Table 66. BioCryst Pharmaceuticals T-Cell Lymphoma Treatment Product
Table 67. BioCryst Pharmaceuticals Revenue in T-Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 68. BioCryst Pharmaceuticals Recent Development
Table 69. Johnson & Johnson Company Details
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson T-Cell Lymphoma Treatment Product
Table 72. Johnson & Johnson Revenue in T-Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis T-Cell Lymphoma Treatment Product
Table 77. Novartis Revenue in T-Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. Merck Company Details
Table 80. Merck Business Overview
Table 81. Merck T-Cell Lymphoma Treatment Product
Table 82. Merck Revenue in T-Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 83. Merck Recent Development
Table 84. Bristol-Myers Squibb Company Details
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb T-Cell Lymphoma Treatment Product
Table 87. Bristol-Myers Squibb Revenue in T-Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 88. Bristol-Myers Squibb Recent Development
Table 89. Genmab AS Company Details
Table 90. Genmab AS Business Overview
Table 91. Genmab AS T-Cell Lymphoma Treatment Product
Table 92. Genmab AS Revenue in T-Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 93. Genmab AS Recent Development
Table 94. Shionogi Company Details
Table 95. Shionogi Business Overview
Table 96. Shionogi T-Cell Lymphoma Treatment Product
Table 97. Shionogi Revenue in T-Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 98. Shionogi Recent Development
Table 99. Spectrum Pharmaceuticals Company Details
Table 100. Spectrum Pharmaceuticals Business Overview
Table 101. Spectrum Pharmaceuticals Revenue in T-Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 102. Spectrum Pharmaceuticals Recent Development
Table 103. Seattle Genetics Company Details
Table 104. Seattle Genetics Business Overview
Table 105. Seattle Genetics T-Cell Lymphoma Treatment Product
Table 106. Seattle Genetics Revenue in T-Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 107. Seattle Genetics Recent Development
Table 108. Shenzhen ChipScreen Biosciences, Ltd. Company Details
Table 109. Shenzhen ChipScreen Biosciences, Ltd. Business Overview
Table 110. Shenzhen ChipScreen Biosciences, Ltd. T-Cell Lymphoma Treatment Product
Table 111. Shenzhen ChipScreen Biosciences, Ltd. Revenue in T-Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 112. Shenzhen ChipScreen Biosciences, Ltd. Recent Development
Table 113. Medivir AB Company Details
Table 114. Medivir AB Business Overview
Table 115. Medivir AB T-Cell Lymphoma Treatment Product
Table 116. Medivir AB Revenue in T-Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 117. Medivir AB Recent Development
Table 118. Amgen Company Details
Table 119. Amgen Business Overview
Table 120. Amgen T-Cell Lymphoma Treatment Product
Table 121. Amgen Revenue in T-Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 122. Amgen Recent Development
Table 123. Eisai Co., Ltd. Company Details
Table 124. Eisai Co., Ltd. Business Overview
Table 125. Eisai Co., Ltd. T-Cell Lymphoma Treatment Product
Table 126. Eisai Co., Ltd. Revenue in T-Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 127. Eisai Co., Ltd. Recent Development
Table 128. Sorrento Therapeutics Company Details
Table 129. Sorrento Therapeutics Business Overview
Table 130. Sorrento Therapeutics T-Cell Lymphoma Treatment Product
Table 131. Sorrento Therapeutics Revenue in T-Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 132. Sorrento Therapeutics Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global T-Cell Lymphoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Surgical Therapy Features
Figure 5. Stem Cell Transplantation Therapy Features
Figure 6. Others Features
Figure 7. Global T-Cell Lymphoma Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Others Case Studies
Figure 12. T-Cell Lymphoma Treatment Report Years Considered
Figure 13. Global T-Cell Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global T-Cell Lymphoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global T-Cell Lymphoma Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global T-Cell Lymphoma Treatment Market Share by Regions (2022-2027)
Figure 17. Global T-Cell Lymphoma Treatment Market Share by Players in 2020
Figure 18. Global Top T-Cell Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-Cell Lymphoma Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by T-Cell Lymphoma Treatment Revenue in 2020
Figure 20. Global T-Cell Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global T-Cell Lymphoma Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America T-Cell Lymphoma Treatment Market Share by Type (2016-2027)
Figure 24. North America T-Cell Lymphoma Treatment Market Share by Application (2016-2027)
Figure 25. North America T-Cell Lymphoma Treatment Market Share by Country (2016-2027)
Figure 26. United States T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe T-Cell Lymphoma Treatment Market Share by Type (2016-2027)
Figure 30. Europe T-Cell Lymphoma Treatment Market Share by Application (2016-2027)
Figure 31. Europe T-Cell Lymphoma Treatment Market Share by Country (2016-2027)
Figure 32. Germany T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific T-Cell Lymphoma Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific T-Cell Lymphoma Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific T-Cell Lymphoma Treatment Market Share by Region (2016-2027)
Figure 42. China T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America T-Cell Lymphoma Treatment Market Share by Type (2016-2027)
Figure 50. Latin America T-Cell Lymphoma Treatment Market Share by Application (2016-2027)
Figure 51. Latin America T-Cell Lymphoma Treatment Market Share by Country (2016-2027)
Figure 52. Mexico T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa T-Cell Lymphoma Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa T-Cell Lymphoma Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa T-Cell Lymphoma Treatment Market Share by Country (2016-2027)
Figure 58. Turkey T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE T-Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. BioCryst Pharmaceuticals Revenue Growth Rate in T-Cell Lymphoma Treatment Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in T-Cell Lymphoma Treatment Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in T-Cell Lymphoma Treatment Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in T-Cell Lymphoma Treatment Business (2016-2021)
Figure 65. Bristol-Myers Squibb Revenue Growth Rate in T-Cell Lymphoma Treatment Business (2016-2021)
Figure 66. Genmab AS Revenue Growth Rate in T-Cell Lymphoma Treatment Business (2016-2021)
Figure 67. Shionogi Revenue Growth Rate in T-Cell Lymphoma Treatment Business (2016-2021)
Figure 68. Spectrum Pharmaceuticals Revenue Growth Rate in T-Cell Lymphoma Treatment Business (2016-2021)
Figure 69. Seattle Genetics Revenue Growth Rate in T-Cell Lymphoma Treatment Business (2016-2021)
Figure 70. Shenzhen ChipScreen Biosciences, Ltd. Revenue Growth Rate in T-Cell Lymphoma Treatment Business (2016-2021)
Figure 71. Medivir AB Revenue Growth Rate in T-Cell Lymphoma Treatment Business (2016-2021)
Figure 72. Amgen Revenue Growth Rate in T-Cell Lymphoma Treatment Business (2016-2021)
Figure 73. Eisai Co., Ltd. Revenue Growth Rate in T-Cell Lymphoma Treatment Business (2016-2021)
Figure 74. Sorrento Therapeutics Revenue Growth Rate in T-Cell Lymphoma Treatment Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous B-Cell Lymphoma Treatment Market The global Cutaneous B-Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…- 世界のB細胞非ホジキンリンパ腫（NHL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market The global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…
- 世界の皮膚T細胞リンパ腫（CTCL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous T-Cell Lymphoma (CTCL) Treatment Market The global Cutaneous T-Cell Lymphoma (CTCL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in an…
- 世界の血管免疫芽球性T細胞リンパ腫（AILT）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment Market The global Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-stand…
- 世界の非ホジキンリンパ腫＆慢性リンパ腫治療市場規模・現状・予測（2021年-2027年） Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of lymphocytes at multiple stages of maturation. There are approximately 30 types of NHLs with varying pathological, clinical, and genetic features. Chronic Lympho…